{
      "Rank": 364,
      "Acronym": [
            "MSC-CY"
      ],
      "AgreementOtherDetails": [],
      "AgreementPISponsorEmployee": [],
      "AgreementRestrictionType": [],
      "AgreementRestrictiveAgreement": [],
      "ArmGroupDescription": [
            "Cyclophosphamide 50 mg/kg/day at +3, +4 day once daily after BMT Mesenchymal stromal cells 1*10^6/kg at day of recovery"
      ],
      "ArmGroupInterventionName": [
            "Drug: Cyclophosphamide",
            "Biological: Mesenchymal stromal cells"
      ],
      "ArmGroupLabel": [
            "MSC+CY"
      ],
      "ArmGroupType": [
            "Experimental"
      ],
      "AvailIPDComment": [],
      "AvailIPDId": [],
      "AvailIPDType": [],
      "AvailIPDURL": [],
      "BaselineCategoryTitle": [],
      "BaselineClassDenomCountGroupId": [],
      "NCTId": [
            "NCT02270307"
      ],
      "BaselineClassDenomCountValue": [],
      "BaselineClassDenomUnits": [],
      "BaselineClassTitle": [],
      "BaselineDenomCountGroupId": [],
      "BaselineDenomCountValue": [],
      "BaselineDenomUnits": [],
      "BaselineGroupDescription": [],
      "BaselineGroupId": [],
      "BaselineGroupTitle": [],
      "BaselineMeasureCalculatePct": [],
      "BaselineMeasureDenomCountGroupId": [],
      "BaselineMeasureDenomCountValue": [],
      "BaselineMeasureDenomUnits": [],
      "BaselineMeasureDenomUnitsSelected": [],
      "BaselineMeasureDescription": [],
      "BaselineMeasureDispersionType": [],
      "BaselineMeasureParamType": [],
      "BaselineMeasurePopulationDescription": [],
      "BaselineMeasureTitle": [],
      "BaselineMeasureUnitOfMeasure": [],
      "BaselineMeasurementComment": [],
      "BaselineMeasurementGroupId": [],
      "BaselineMeasurementLowerLimit": [],
      "BaselineMeasurementSpread": [],
      "BaselineMeasurementUpperLimit": [],
      "BaselineMeasurementValue": [],
      "BaselinePopulationDescription": [],
      "BaselineTypeUnitsAnalyzed": [],
      "BioSpecDescription": [],
      "BioSpecRetention": [],
      "BriefSummary": [
            "Evaluating the effectiveness of the new protocol which replace the standard immunosuppressive therapy with use of MSCs and CY in patients at high risk of relapse."
      ],
      "BriefTitle": [
            "MSC and Cyclophosphamide for Acute Graft-Versus-Host Disease (aGVHD) Prophylaxis"
      ],
      "CentralContactEMail": [
            "elenap@blood.ru",
            "mdrokov@gmail.com"
      ],
      "CentralContactName": [
            "Elena N Parovichnikova, PhD,MD",
            "Mikhail Y Drokov, PhD,MD"
      ],
      "CentralContactPhone": [
            "+79161252623",
            "+79261841813"
      ],
      "CentralContactPhoneExt": [],
      "CentralContactRole": [
            "Contact",
            "Contact"
      ],
      "CollaboratorClass": [],
      "CollaboratorName": [],
      "CompletionDate": [
            "January 2016"
      ],
      "CompletionDateType": [
            "Anticipated"
      ],
      "Condition": [
            "Leukemia",
            "Multiple Myeloma"
      ],
      "ConditionAncestorId": [
            "D000054219",
            "D000009370",
            "D000009369",
            "D000020141",
            "D000014652",
            "D000002318",
            "D000010265",
            "D000001796",
            "D000006402",
            "D000006474",
            "D000008232",
            "D000007160",
            "D000007154"
      ],
      "ConditionAncestorTerm": [
            "Neoplasms, Plasma Cell",
            "Neoplasms by Histologic Type",
            "Neoplasms",
            "Hemostatic Disorders",
            "Vascular Diseases",
            "Cardiovascular Diseases",
            "Paraproteinemias",
            "Blood Protein Disorders",
            "Hematologic Diseases",
            "Hemorrhagic Disorders",
            "Lymphoproliferative Disorders",
            "Immunoproliferative Disorders",
            "Immune System Diseases"
      ],
      "ConditionBrowseBranchAbbrev": [
            "BC04",
            "BC14",
            "BC15",
            "BC20",
            "All",
            "Rare"
      ],
      "ConditionBrowseBranchName": [
            "Neoplasms",
            "Heart and Blood Diseases",
            "Blood and Lymph Conditions",
            "Immune System Diseases",
            "All Conditions",
            "Rare Diseases"
      ],
      "ConditionBrowseLeafAsFound": [
            "Multiple Myeloma",
            "Multiple Myeloma"
      ],
      "ConditionBrowseLeafId": [
            "M11210",
            "M26741",
            "M10097",
            "M20467",
            "M8341",
            "M11467",
            "M21130",
            "M4211",
            "M16552",
            "M12330",
            "M4229",
            "M8642",
            "M8712",
            "M10377",
            "M9358",
            "M9352",
            "T3947",
            "T2832",
            "T170"
      ],
      "ConditionBrowseLeafName": [
            "Multiple Myeloma",
            "Neoplasms, Plasma Cell",
            "Leukemia",
            "Hematologic Neoplasms",
            "Graft vs Host Disease",
            "Neoplasms by Histologic Type",
            "Hemostatic Disorders",
            "Blood Coagulation Disorders",
            "Vascular Diseases",
            "Paraproteinemias",
            "Blood Protein Disorders",
            "Hematologic Diseases",
            "Hemorrhagic Disorders",
            "Lymphoproliferative Disorders",
            "Immunoproliferative Disorders",
            "Immune System Diseases",
            "Multiple Myeloma",
            "Homologous Wasting Disease",
            "Acute Graft Versus Host Disease"
      ],
      "ConditionBrowseLeafRelevance": [
            "high",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "high",
            "low",
            "low"
      ],
      "ConditionMeshId": [
            "D000009101"
      ],
      "ConditionMeshTerm": [
            "Multiple Myeloma"
      ],
      "DelayedPosting": [],
      "DesignAllocation": [
            "N/A"
      ],
      "DesignInterventionModel": [
            "Single Group Assignment"
      ],
      "DesignInterventionModelDescription": [],
      "DesignMasking": [
            "None (Open Label)"
      ],
      "DesignMaskingDescription": [],
      "DesignObservationalModel": [],
      "DesignPrimaryPurpose": [
            "Prevention"
      ],
      "DesignTimePerspective": [],
      "DesignWhoMasked": [],
      "DetailedDescription": [
            "This trial try to find a new way of refractory hematological malignancies treatment. Aim of this study evaluating the effectiveness of the new protocol which replace the standard immunosuppressive therapy with use of MSCs and CY in patients at high risk of relapse."
      ],
      "DispFirstPostDate": [],
      "DispFirstPostDateType": [],
      "DispFirstSubmitDate": [],
      "DispFirstSubmitQCDate": [],
      "EligibilityCriteria": [
            "Inclusion Criteria:\n\nRefractory forms of acute leukemia, but in complete remission (CR)\nSecond and third remission of acute leukemia\n2nd and 3rd chronic phase chronic myelogenous leukemia (CML) (or Ph + ALL)\nrelapsed multiple myeloma\nadvanced leukemia\n\nExclusion Criteria:\n\nICU\nMechanical ventilation"
      ],
      "EnrollmentCount": [
            "40"
      ],
      "EnrollmentType": [
            "Anticipated"
      ],
      "EventGroupDeathsNumAffected": [],
      "EventGroupDeathsNumAtRisk": [],
      "EventGroupDescription": [],
      "EventGroupId": [],
      "EventGroupOtherNumAffected": [],
      "EventGroupOtherNumAtRisk": [],
      "EventGroupSeriousNumAffected": [],
      "EventGroupSeriousNumAtRisk": [],
      "EventGroupTitle": [],
      "EventsDescription": [],
      "EventsFrequencyThreshold": [],
      "EventsTimeFrame": [],
      "ExpAccTypeIndividual": [],
      "ExpAccTypeIntermediate": [],
      "ExpAccTypeTreatment": [],
      "ExpandedAccessNCTId": [],
      "ExpandedAccessStatusForNCTId": [],
      "FDAAA801Violation": [],
      "FlowAchievementComment": [],
      "FlowAchievementGroupId": [],
      "FlowAchievementNumSubjects": [],
      "FlowAchievementNumUnits": [],
      "FlowDropWithdrawComment": [],
      "FlowDropWithdrawType": [],
      "FlowGroupDescription": [],
      "FlowGroupId": [],
      "FlowGroupTitle": [],
      "FlowMilestoneComment": [],
      "FlowMilestoneType": [],
      "FlowPeriodTitle": [],
      "FlowPreAssignmentDetails": [],
      "FlowReasonComment": [],
      "FlowReasonGroupId": [],
      "FlowReasonNumSubjects": [],
      "FlowReasonNumUnits": [],
      "FlowRecruitmentDetails": [],
      "FlowTypeUnitsAnalyzed": [],
      "Gender": [
            "All"
      ],
      "GenderBased": [],
      "GenderDescription": [],
      "HasExpandedAccess": [
            "No"
      ],
      "HealthyVolunteers": [
            "No"
      ],
      "IPDSharing": [],
      "IPDSharingAccessCriteria": [],
      "IPDSharingDescription": [],
      "IPDSharingInfoType": [],
      "IPDSharingTimeFrame": [],
      "IPDSharingURL": [],
      "InterventionAncestorId": [
            "D000007166",
            "D000007155",
            "D000045505",
            "D000018501",
            "D000018906",
            "D000000477",
            "D000045504",
            "D000000970",
            "D000019653"
      ],
      "InterventionAncestorTerm": [
            "Immunosuppressive Agents",
            "Immunologic Factors",
            "Physiological Effects of Drugs",
            "Antirheumatic Agents",
            "Antineoplastic Agents, Alkylating",
            "Alkylating Agents",
            "Molecular Mechanisms of Pharmacological Action",
            "Antineoplastic Agents",
            "Myeloablative Agonists"
      ],
      "InterventionArmGroupLabel": [
            "MSC+CY",
            "MSC+CY"
      ],
      "InterventionBrowseBranchAbbrev": [
            "ANeo",
            "ARhu",
            "All"
      ],
      "InterventionBrowseBranchName": [
            "Antineoplastic Agents",
            "Antirheumatic Agents",
            "All Drugs and Chemicals"
      ],
      "InterventionBrowseLeafAsFound": [
            "Tablet"
      ],
      "InterventionBrowseLeafId": [
            "M5879",
            "M9364",
            "M9353",
            "M19757",
            "M20095",
            "M2972"
      ],
      "InterventionBrowseLeafName": [
            "Cyclophosphamide",
            "Immunosuppressive Agents",
            "Immunologic Factors",
            "Antirheumatic Agents",
            "Antineoplastic Agents, Alkylating",
            "Alkylating Agents"
      ],
      "InterventionBrowseLeafRelevance": [
            "high",
            "low",
            "low",
            "low",
            "low",
            "low"
      ],
      "InterventionDescription": [
            "Dose 50 mg/kg at day +3,+4 once daily",
            "Dose 1 million per kg, at day of recovery once"
      ],
      "InterventionMeshId": [
            "D000003520"
      ],
      "InterventionMeshTerm": [
            "Cyclophosphamide"
      ],
      "InterventionName": [
            "Cyclophosphamide",
            "Mesenchymal stromal cells"
      ],
      "InterventionOtherName": [],
      "InterventionType": [
            "Drug",
            "Biological"
      ],
      "IsFDARegulatedDevice": [],
      "IsFDARegulatedDrug": [],
      "IsPPSD": [],
      "IsUSExport": [],
      "IsUnapprovedDevice": [],
      "Keyword": [],
      "LargeDocDate": [],
      "LargeDocFilename": [],
      "LargeDocHasICF": [],
      "LargeDocHasProtocol": [],
      "LargeDocHasSAP": [],
      "LargeDocLabel": [],
      "LargeDocTypeAbbrev": [],
      "LargeDocUploadDate": [],
      "LastKnownStatus": [
            "Recruiting"
      ],
      "LastUpdatePostDate": [
            "October 21, 2014"
      ],
      "LastUpdatePostDateType": [
            "Estimate"
      ],
      "LastUpdateSubmitDate": [
            "October 17, 2014"
      ],
      "LeadSponsorClass": [
            "NETWORK"
      ],
      "LeadSponsorName": [
            "National Research Center for Hematology, Russia"
      ],
      "LimitationsAndCaveatsDescription": [],
      "LocationCity": [
            "Moscow"
      ],
      "LocationContactEMail": [
            "kuzlara@rambler.ru"
      ],
      "LocationContactName": [
            "Elena Parovichnikova, Prof MD PhD",
            "Elena Parovichnikova"
      ],
      "LocationContactPhone": [
            "+79161487131"
      ],
      "LocationContactPhoneExt": [],
      "LocationContactRole": [
            "Contact",
            "Principal Investigator"
      ],
      "LocationCountry": [
            "Russian Federation"
      ],
      "LocationFacility": [
            "BMT department"
      ],
      "LocationState": [],
      "LocationStatus": [
            "Recruiting"
      ],
      "LocationZip": [],
      "MaximumAge": [
            "65 Years"
      ],
      "MinimumAge": [
            "18 Years"
      ],
      "NCTIdAlias": [],
      "OfficialTitle": [
            "Allogeneic Bone Marrow Transplantation (Allo-BMT) From Human Leukocyte Antigen (HLA) - Identical Related and Unrelated Donors in Patients With Hematological Malignancies With High Risk of Relapse Using Cyclophosphamide (CY) and Mesenchymal Stromal Cells (MSC) as aGVHD Prophylaxis"
      ],
      "OrgClass": [
            "NETWORK"
      ],
      "OrgFullName": [
            "National Research Center for Hematology, Russia"
      ],
      "OrgStudyId": [
            "MSC-CY-Russia"
      ],
      "OrgStudyIdDomain": [],
      "OrgStudyIdLink": [],
      "OrgStudyIdType": [],
      "OtherEventAssessmentType": [],
      "OtherEventNotes": [],
      "OtherEventOrganSystem": [],
      "OtherEventSourceVocabulary": [],
      "OtherEventStatsGroupId": [],
      "OtherEventStatsNumAffected": [],
      "OtherEventStatsNumAtRisk": [],
      "OtherEventStatsNumEvents": [],
      "OtherEventTerm": [],
      "OtherOutcomeDescription": [],
      "OtherOutcomeMeasure": [],
      "OtherOutcomeTimeFrame": [],
      "OutcomeAnalysisCILowerLimit": [],
      "OutcomeAnalysisCILowerLimitComment": [],
      "OutcomeAnalysisCINumSides": [],
      "OutcomeAnalysisCIPctValue": [],
      "OutcomeAnalysisCIUpperLimit": [],
      "OutcomeAnalysisCIUpperLimitComment": [],
      "OutcomeAnalysisDispersionType": [],
      "OutcomeAnalysisDispersionValue": [],
      "OutcomeAnalysisEstimateComment": [],
      "OutcomeAnalysisGroupDescription": [],
      "OutcomeAnalysisGroupId": [],
      "OutcomeAnalysisNonInferiorityComment": [],
      "OutcomeAnalysisNonInferiorityType": [],
      "OutcomeAnalysisOtherAnalysisDescription": [],
      "OutcomeAnalysisPValue": [],
      "OutcomeAnalysisPValueComment": [],
      "OutcomeAnalysisParamType": [],
      "OutcomeAnalysisParamValue": [],
      "OutcomeAnalysisStatisticalComment": [],
      "OutcomeAnalysisStatisticalMethod": [],
      "OutcomeAnalysisTestedNonInferiority": [],
      "OutcomeCategoryTitle": [],
      "OutcomeClassDenomCountGroupId": [],
      "OutcomeClassDenomCountValue": [],
      "OutcomeClassDenomUnits": [],
      "OutcomeClassTitle": [],
      "OutcomeDenomCountGroupId": [],
      "OutcomeDenomCountValue": [],
      "OutcomeDenomUnits": [],
      "OutcomeGroupDescription": [],
      "OutcomeGroupId": [],
      "OutcomeGroupTitle": [],
      "OutcomeMeasureAnticipatedPostingDate": [],
      "OutcomeMeasureCalculatePct": [],
      "OutcomeMeasureDenomUnitsSelected": [],
      "OutcomeMeasureDescription": [],
      "OutcomeMeasureDispersionType": [],
      "OutcomeMeasureParamType": [],
      "OutcomeMeasurePopulationDescription": [],
      "OutcomeMeasureReportingStatus": [],
      "OutcomeMeasureTimeFrame": [],
      "OutcomeMeasureTitle": [],
      "OutcomeMeasureType": [],
      "OutcomeMeasureTypeUnitsAnalyzed": [],
      "OutcomeMeasureUnitOfMeasure": [],
      "OutcomeMeasurementComment": [],
      "OutcomeMeasurementGroupId": [],
      "OutcomeMeasurementLowerLimit": [],
      "OutcomeMeasurementSpread": [],
      "OutcomeMeasurementUpperLimit": [],
      "OutcomeMeasurementValue": [],
      "OverallOfficialAffiliation": [
            "Ministry of Health"
      ],
      "OverallOfficialName": [
            "Valery Savchenko, Prof."
      ],
      "OverallOfficialRole": [
            "Study Director"
      ],
      "OverallStatus": [
            "Unknown status"
      ],
      "OversightHasDMC": [
            "No"
      ],
      "PatientRegistry": [],
      "Phase": [
            "Phase 2",
            "Phase 3"
      ],
      "PointOfContactEMail": [],
      "PointOfContactOrganization": [],
      "PointOfContactPhone": [],
      "PointOfContactPhoneExt": [],
      "PointOfContactTitle": [],
      "PrimaryCompletionDate": [
            "January 2016"
      ],
      "PrimaryCompletionDateType": [
            "Anticipated"
      ],
      "PrimaryOutcomeDescription": [],
      "PrimaryOutcomeMeasure": [
            "Overall survival"
      ],
      "PrimaryOutcomeTimeFrame": [
            "1 year"
      ],
      "ReferenceCitation": [],
      "ReferencePMID": [],
      "ReferenceType": [],
      "RemovedCountry": [],
      "ResponsiblePartyInvestigatorAffiliation": [
            "National Research Center for Hematology, Russia"
      ],
      "ResponsiblePartyInvestigatorFullName": [
            "Elena N.Parovichnikova"
      ],
      "ResponsiblePartyInvestigatorTitle": [
            "PI"
      ],
      "ResponsiblePartyOldNameTitle": [],
      "ResponsiblePartyOldOrganization": [],
      "ResponsiblePartyType": [
            "Principal Investigator"
      ],
      "ResultsFirstPostDate": [],
      "ResultsFirstPostDateType": [],
      "ResultsFirstPostedQCCommentsDate": [],
      "ResultsFirstPostedQCCommentsDateType": [],
      "ResultsFirstSubmitDate": [],
      "ResultsFirstSubmitQCDate": [],
      "RetractionPMID": [],
      "RetractionSource": [],
      "SamplingMethod": [],
      "SecondaryId": [],
      "SecondaryIdDomain": [],
      "SecondaryIdLink": [],
      "SecondaryIdType": [],
      "SecondaryOutcomeDescription": [],
      "SecondaryOutcomeMeasure": [],
      "SecondaryOutcomeTimeFrame": [],
      "SeeAlsoLinkLabel": [],
      "SeeAlsoLinkURL": [],
      "SeriousEventAssessmentType": [],
      "SeriousEventNotes": [],
      "SeriousEventOrganSystem": [],
      "SeriousEventSourceVocabulary": [],
      "SeriousEventStatsGroupId": [],
      "SeriousEventStatsNumAffected": [],
      "SeriousEventStatsNumAtRisk": [],
      "SeriousEventStatsNumEvents": [],
      "SeriousEventTerm": [],
      "StartDate": [
            "January 2014"
      ],
      "StartDateType": [],
      "StatusVerifiedDate": [
            "October 2014"
      ],
      "StdAge": [
            "Adult",
            "Older Adult"
      ],
      "StudyFirstPostDate": [
            "October 21, 2014"
      ],
      "StudyFirstPostDateType": [
            "Estimate"
      ],
      "StudyFirstSubmitDate": [
            "April 7, 2014"
      ],
      "StudyFirstSubmitQCDate": [
            "October 17, 2014"
      ],
      "StudyPopulation": [],
      "StudyType": [
            "Interventional"
      ],
      "SubmissionMCPReleaseN": [],
      "SubmissionReleaseDate": [],
      "SubmissionResetDate": [],
      "SubmissionUnreleaseDate": [],
      "TargetDuration": [],
      "UnpostedEventDate": [],
      "UnpostedEventType": [],
      "UnpostedResponsibleParty": [],
      "VersionHolder": [
            "October 10, 2022"
      ],
      "WhyStopped": []
}